HomeOTLK • NASDAQ
add
Outlook Therapeutics Inc
Previous close
$8.17
Day range
$7.80 - $8.37
Year range
$4.00 - $40.60
Market cap
180.40M USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.79M | -0.55% |
Net income | -11.18M | 40.10% |
Net profit margin | — | — |
Earnings per share | -0.78 | 51.19% |
EBITDA | -10.29M | 34.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.36M | -80.21% |
Total assets | 21.68M | -65.41% |
Total liabilities | 46.03M | -1.92% |
Total equity | -24.34M | — |
Shares outstanding | 13.01M | — |
Price to book | -4.37 | — |
Return on assets | -95.61% | — |
Return on capital | -154.91% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -11.18M | 40.10% |
Cash from operations | -13.03M | -46.41% |
Cash from investing | — | — |
Cash from financing | -3.18K | -100.01% |
Net change in cash | -13.04M | -137.30% |
Free cash flow | -9.35M | -226.28% |
About
Founded
2010
Website
Employees
24